Like pan-NOS inhibition, the iNOS inhibitor restores exacerbated BBB dysfunction and astrocytic CCL2 production in Slc4a4-icKO mice after stroke (Figures S12B–S12F). This evidence concerns the gene CCL2 and stroke disorder.